FDA.reportPublic FDA data

NDC 70504-0126-1 - VARIZIG

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70504-0126
Requested NDC
70504-0126-1
Package NDCs from labels
70504-0126-1, 70504-0126-2
Manufacturer
Aptevo BioTherapeutics LLC
Effective date
2018-12-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
VARIZIG - Aptevo BioTherapeutics LLCAptevo BioTherapeutics LLC2018-12-14HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70504-0126-22023-02-01C16284748780-1d6a99b39-9e00-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use VARIZIG ® safely and effectively. See full prescribing information for VARIZIG. VARIZIG ® [Varicella Zoster Immune Globulin (Human)] for intramuscular administration only. Sterile Solution for Injection Initial U.S. Approval: 2012
70504-0126-22022-01-28C16284748780-1d6a99b39-9e00-a426-e053-dadaa90af4c2These highlights do not include all the information needed to use VARIZIG ® safely and effectively. See full prescribing information for VARIZIG. VARIZIG ® [Varicella Zoster Immune Globulin (Human)] for intramuscular administration only. Sterile Solution for Injection Initial U.S. Approval: 2012

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70504-0126-1ML - Milliliter70504-0126a6320170-6180-42cf-b4af-57ff8fb939a212017-07-07
70504-0126-2ML - Milliliter70504-012647fe4a89-7b20-423b-a92a-8c64ef368dab12017-07-07

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Rohto Max StrengthNAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80The Mentholatum Companye4b49550-1ca3-4bd7-854d-409b53fa5e262026-08-20WarningsExact identifier
unii: 6OZP39ZG8H
Droptics Dry Eye ReliefCARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80Droptics LLC29d7614b-f4b7-48e2-97c5-d1bff27731d22026-07-22WarningsExact identifier
unii: 6OZP39ZG8H
Rohto Cool ReliefNAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80The Mentholatum Companydc8f1ff3-87ae-47ca-815f-5a0e34f8cf302026-06-19WarningsExact identifier
unii: 6OZP39ZG8H
Refresh Optive Mega-3 PFCARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80Allergan, Inc.326cb5d6-c784-404f-9a13-6d69262dda6e2026-03-01WarningsExact identifier
unii: 6OZP39ZG8H
Virus Nosode 4003VIRUS NOSODEProfessional Complementary Health Formulas626d937d-45db-4ccf-a75b-e961e2a808522026-01-08WarningsExact identifier
unii: 33T61IWL27
Low Virus Nosode 4023LOW VIRUS NOSODEProfessional Complementary Health Formulas670965b0-9b0b-4068-b089-701db0a5ac132026-01-08WarningsExact identifier
unii: 33T61IWL27
Childhood Immunization Detox 6032CHILDHOOD IMMUNIZATION DETOXProfessional Complementary Health Formulas4d455d07-3197-44d6-99d6-488fcdb50f952026-01-08WarningsExact identifier
unii: 33T61IWL27
Childhood Diseases Nosode Combination 9408CHILDHOOD DISEASES NOSODE COMBINATIONProfessional Complementary Health Formulasa9a7ffcf-03a7-4799-9574-fbbba8a757122026-01-08WarningsExact identifier
unii: 33T61IWL27
Shingles Nosode 4028SHINGLES NOSODEProfessional Complementary Health Formulase71d917a-af9f-41e9-a3de-cb588db7e0222026-01-08WarningsExact identifier
unii: 33T61IWL27
Refresh Digital PFCARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80Allergan, Inc.97e83e68-6374-4df4-93f6-d707fc32748d2022-11-28WarningsExact identifier
unii: 6OZP39ZG8H
Refresh DigitalCARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80Allergan, Inc.b2bd34d4-fab9-4f4b-9be2-5d30b55f5b812022-11-28WarningsExact identifier
unii: 6OZP39ZG8H
REFRESH OPTIVE AdvancedCARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80Allergan, Inc.ebd0839e-2e1d-4e0e-986c-19f1f5c763582022-09-15WarningsExact identifier
unii: 6OZP39ZG8H
REFRESH OPTIVE AdvancedCARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80Allergan, Inc.aaa943e4-7c38-4c5a-b7c0-5a656d8cafc02022-09-01WarningsExact identifier
unii: 6OZP39ZG8H
REFRESH Optive Mega-3CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80Allergan, Inc.c5f2b3f2-2071-45bd-a010-67f848bc02332022-06-30WarningsExact identifier
unii: 6OZP39ZG8H
793ef00e-1161-4632-b68d-46a6418a1e2cc27a87e0-9953-4425-acec-16f7ed8ede642016-08-19Warnings, Adverse reactionsExact identifier
spl set id: c27a87e0-9953-4425-acec-16f7ed8ede64

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.